Leapfrog Ruling Raises Strategic Questions for Hospital CFOs
By Marie DeFreitas
A federal court ruling against The Leapfrog Group is raising new questions about how hospital safety ratings are calculated and how much influence those ratings have on patient decisions and hospital reputations.
U.S. District Judge Donald M. Middlebrooks recently ordered Leapfrog to remove safety grades assigned to five hospitals owned by Tenet Healthcare in Florida. The facilities, which are a part of Tenet’s Palm Beach Health Network, had received “D” or “F” grades after declining to participate in Leapfrog’s voluntary hospital safety survey.
The court concluded that Leapfrog’s methodology unfairly penalized hospitals that chose not to submit survey data. According to the ruling, the organization assigned the lowest possible scores on several safety measures when hospitals did not participate in the survey, a practice the judge said had “no scientific basis” and ultimately misrepresented hospital safety.
Leapfrog publishes hospital safety grades twice a year, grading hospitals from A to F based on measures like infection rates, staffing practices, and error prevention systems. The organization argues the grades help consumers evaluate patient safety and also drive quality improvement. Research cited by Leapfrog suggests patients face significantly higher risks of preventable harm in hospitals receiving lower grades.
The five Tenet hospitals involved in the lawsuit had previously scored highly when they participated in the survey but saw their ratings sharply decline after deciding to opt out. Hospital executives testified that the failing grades damaged public perception and caused some patients to delay or refuse care.
As part of the ruling, Leapfrog must remove the disputed grades, refrain from using the methodology on those hospitals and issue corrective disclosures to organizations that licensed the ratings during the affected periods.
Leapfrog said, while it will abide by the ruling for now, it plans to appeal the decision, arguing the ruling threatens the ability of independent organizations to publish ratings and opinions about healthcare quality.
The CFO scoop
For CFOs, the decision underscores the operational and financial stakes tied to third-party quality ratings. Ratings from organizations like Leapfrog can influence patient volume, payer relationships, employer contracting and reputation, all factors that ultimately affect revenue and market share.
The ruling may embolden hospitals to challenge ratings methodologies they believe are misleading, but it also highlights the strategic decision CFOs face around participation in voluntary reporting programs. Opting in can require extensive administrative and data-collection resources, as well as a significant amount of time, while opting out may carry reputational risk if ratings organizations decide to penalize nonparticipants.
Going forward, CFOs may take a more proactive role in managing ratings exposure by treating participation, data governance, and methodology oversight as part of broader reputation and market strategy.
In an environment where quality scores can influence both patient trust and revenue streams, understanding how those metrics are constructed may be as important as the scores themselves.
Marie DeFreitas is the CFO editor for HealthLeaders.